Randomized Trial of a Novel CMV Vaccine (CMVPepVax) after Allogeneic HCT: Elevated CMV-Specific Immune Response, Reduction in Chronic GvHD and CMV Reactivation Only in Vaccine Arm Patients - Nakamura, Ryotaro; La Rosa, Corinna; Longmate, Jeff; O’Donnell, Margaret; Cai, Ji-Lian; Farol, Len; Salhotra, Amandeep; Snyder, David S; Drake, Jennifer; Slape, Cynthia; Merson, James; Zaia, John A; et al. (Blood, 2014)